Partnership will Expand Shoulder Innovations’ Disruptive Ecosystem with Advanced Enabling Technology, Complementing Surgeon and Patient Needs in the ASC
Shoulder Innovations, Inc., a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, announced a strategic partnership with Interventional Systems (INS), a developer of robotic solutions for minimally invasive surgery, to introduce a transformative shoulder-specific micro-robotic solution designed to further enhance shoulder surgical precision, workflow efficiency, and enable exciting, new clinical approaches in the total shoulder arthroplasty and reverse shoulder arthroplasty markets.
Health Technology Insights: Zydus, RK Pharma Sign US Oncology Support Deal
This partnership will broaden Shoulder Innovations’ disruptive ecosystem with more advanced enabling technology. Once developed, this new robotic solution will integrate with the Company’s ProVoyance platform to deliver a comprehensive enabling technology solution, with the goal of improving surgical accuracy and workflow, while meeting the needs of patients and surgeons across all sites of care, particularly ambulatory surgery centers (ASCs). To further support mobility and ease of implementation, the robot is designed to be transported directly into the operating room as a portable unit.
This partnership will broaden Shoulder Innovations’ disruptive ecosystem with more advanced enabling technology.
With this system, Shoulder Innovations plans to address many of the challenges associated with robotic surgery, including high implementation costs, difficult mobility, costly perioperative inefficiencies, and steep technical learning curves. Orthopedic shoulder surgeons, healthcare facilities, and patients are expected to benefit from a portable solution that facilitates streamlined and consistent surgical workflows, ease-of-use, and real-time adjustments during surgery.
Health Technology Insights: Novo Nordisk Files for FDA Approval of a Higher Dose of Wegovy Injection 7.2 MG
“We are thrilled to see our innovations resonating with the market and driving rapid share gains,” said Rob Ball, CEO of Shoulder Innovations. “Our team has helped deliver some of the most transformative advances in shoulder arthroplasty and we are applying that experience and capital raised through our recent IPO to introduce a finely tuned enabling technology platform for shoulder surgical care. While this latest addition will improve shoulder surgery in its current form, we are excited about how we can further reshape the marketplace as the true capabilities of our broader technology are developed and deployed. These solutions stand to transform every operating room into a robotic environment, leveraging a platform from INS already proven in other markets to maximize our ability to execute efficiently.”
“INS has a strong track record of deploying our micro-robotic technology across multiple U.S. healthcare markets with large strategic partners. We identified the fast-growing shoulder arthroplasty market as our next step and Shoulder Innovations as the ideal partner,” said Pedro Costa, Chief Strategy Officer of INS. “We are excited to work together to bring this technology to market and advance our shared goal of using micro-robotics to make procedures more efficient, precise, and cost-effective.”
Health Technology Insights: Chris Cleary Named Chairman at Restore Medical
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
Source- PR Newswire
